⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
Pomerantz LLP Calls Attention to Class Action Filed Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Calls Attention to Class Action Filed Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY